NHS-MMAF - CAS# 1404073-19-3 mecrolimus InChi: InChI=1S/C23H27N3O5/c1-6-15(17-10-13(11-31-17)12(2)3)24-18-19(22(29)21(18)28)25-16-9-7-8-14(20(16)27)23(30)26(4)5/h7-12

InChi: InChI=1S/C23H27N3O5/c1-6-15(17-10-13(11-31-17)12(2)3)24-18-19(22(29)21(18)28)25-16-9-7-8-14(20(16)27)23(30)26(4)5/h7-12

4 mg of protopine per kg of body weight

InChi: InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5

Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle

N6-Furfuryladenosine

NHS-MMAF - CAS# 1404073-19-3 mecrolimus InChi: InChI=1S/C23H27N3O5/c1-6-15(17-10-13(11-31-17)12(2)3)24-18-19(22(29)21(18)28)25-16-9-7-8-14(20(16)27)23(30)26(4)5/h7-12NHS MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization inhibitor and is used as a antitumor agent Product information CAS Number: 1404073 19 3 Molecular Weight: 943. 18 Formula: C49H78N6O12 Chemical Name: ((2R, 3R) 3 ((S) 1 ((3R, 4S, 5S) 4 ((S) 2 ((S) 2 ((6 ((2, 5 dioxopyrrolidin 1 yl)oxy) 6 oxohexyl)(methyl)amino) 3 methylbutanamido) N, 3 dimethylbutanamido) 3 methoxy 5